22 related articles for article (PubMed ID: 1650487)
1. Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients.
Patkar AA; Mannelli P; Peindl K; Hill KP; Gopalakrishnan R; Berrettini WH
Psychopharmacology (Berl); 2006 Mar; 185(1):123-32. PubMed ID: 16418827
[TBL] [Abstract][Full Text] [Related]
2. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
Benjamin J; Greenberg BD; Murphy DL
Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
[TBL] [Abstract][Full Text] [Related]
3. Panic disorder. Pathophysiology and drug treatment.
Johnson MR; Lydiard RB; Ballenger JC
Drugs; 1995 Mar; 49(3):328-44. PubMed ID: 7774510
[TBL] [Abstract][Full Text] [Related]
4. Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects.
Kahn RS; Kling MA; Wetzler S; Asnis GM; van Praag H
Psychopharmacology (Berl); 1992; 108(1-2):225-8. PubMed ID: 1410142
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
[TBL] [Abstract][Full Text] [Related]
6. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
[TBL] [Abstract][Full Text] [Related]
7. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
[TBL] [Abstract][Full Text] [Related]
8. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
Kahn RS; Siever LJ; Gabriel S; Amin F; Stern RG; DuMont K; Apter S; Davidson M
Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094
[TBL] [Abstract][Full Text] [Related]
9. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
Charney DS; Woods SW; Goodman WK; Heninger GR
Psychopharmacology (Berl); 1987; 92(1):14-24. PubMed ID: 3110824
[TBL] [Abstract][Full Text] [Related]
10. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.
Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM
Psychiatry Res; 1991 Apr; 37(1):25-34. PubMed ID: 1650487
[TBL] [Abstract][Full Text] [Related]
11. m-Chlorophenylpiperazine as a probe of serotonin function.
Kahn RS; Wetzler S
Biol Psychiatry; 1991 Dec; 30(11):1139-66. PubMed ID: 1663792
[TBL] [Abstract][Full Text] [Related]
12. Increased anxiogenic effects of caffeine in panic disorders.
Charney DS; Heninger GR; Jatlow PI
Arch Gen Psychiatry; 1985 Mar; 42(3):233-43. PubMed ID: 2983630
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
